Ama and its formation
How much weight this concept bears. Ama has no operational definition that anyone outside the tradition could apply, and no validated biological correlate. Every ama measurement located in the peer-reviewed literature is a symptom checklist assembled from the same classical verses that define the concept, which makes validation circular: the instrument agrees with the doctrine because it was built from it. Three studies located here attempt to break that circle, and none succeeded cleanly. The Ama Assessment Instrument correlated with ESR at r=0.287 at baseline, falling to 0.160 by the third follow-up, and with DAS-28 at r=0.231 at baseline (PMID 36822147), weak enough that the authors reframed the weakness as evidence of independence, and a later group abandoned those comparators entirely (PMID 42497784). The stronger correlation with CDAI (r=0.645) in that later study is the best result located but comes from 38 RA patients and against a composite that is itself largely subjective, so it may reflect general illness severity; that same group's proposal to merge the Ama-score and CDAI into one composite is difficult to reconcile with the score measuring something CDAI does not, which is the gatherer's reading of the proposal and not a position either author states. The only attempt located at an observer-independent measure, tongue-coating photography scored by five clinicians, failed its pre-specified analysis outright (PMID 42142499) and survives only through post-hoc regional subgroups. A fourth study is sometimes read as relevant and is not an attempt on the circularity: the untargeted metabolomics of RA patients on Ayurvedic treatment (PMID 38972279) neither defines nor scores ama, so it cannot test an ama measure. It is recorded above because it is the one open-ended biochemical method located in this area, and it produced no ama-specific signature. The mechanistic correlates named in Ayurvedic writing are not addressable from that writing alone. Free radicals were proposed in 1999 (PMID 22556911) with no data. Gut dysbiosis is proposed in narrative review (PMID 33281390), which argues from the classical diet rules for amavata to published effects of individual foods without measuring ama or microbiota in anyone. Endotoxin and intestinal permeability are invoked by analogy to a primary literature that the Ayurvedic sources do not cite and that does not mention ama: the metabolic-endotoxemia work, which is a mouse study (PMID 17456850), and the zonulin barrier-function review (PMID 21248165). Those two are recorded above so that the analogy is at least checkable. No study located in the searches recorded under gatheringNotes measures endotoxin, permeability, dysbiosis or an oxidative marker against any ama assessment, and the searches that were run are named there so the limits of that statement are visible. The concept also carries an unresolved internal problem that the modern literature located here does not engage: Charaka's ama, as rendered by his public-domain translator, is largely literal undigested food and undigested rasa in the gut, whereas the systemic circulating toxin of modern Ayurvedic writing owes more to Vagbhata and to twentieth-century reinterpretation. A second problem, whether ama names anything beyond the consequences of weak agni, is recorded under notKnown rather than asserted here, because no source located poses it. What this record supports is narrow. Ama is the traditional name for a symptom cluster of heaviness, lassitude, anorexia, coated tongue and impaired digestion; that cluster can be scored by a single examiner using a checklist derived from the classical signs; whether two examiners scoring the same patient would agree is not known, which is notKnown item 4; and nothing located here establishes ama as a distinct substance or process rather than a name for the cluster. The record makes no claim that the concept is clinically usable or that the cluster tracks any distinct underlying process, because it holds no evidence that would support either.
Ama is the Ayurvedic name for the product of failed digestion: material that has been taken in but not properly transformed, and which is held to become a cause of disease rather than a source of nourishment. The classical mechanism is straightforward in outline. When agni is weakened by fasting, overeating, incompatible or heavy food, mistimed therapy, illness, seasonal mismatch or suppression of natural urges, food is not digested, and the undigested residue is said to turn sour and to act like a poison. Charaka describes this material combining with each of the doshas to produce their characteristic diseases, entering urine, stool and the tissues, and in acute form producing the conditions visuchika and alasaka, which he says physicians call ama-visha, the poison of undigested food, because the symptoms resemble poisoning. Later texts, principally Vagbhata, reify ama into a general morbid substance that blocks the channels and adheres to doshas to make them sama, with a standard ten-sign checklist (heaviness, lassitude, loss of appetite, coated tongue, malaise and so on) distinguishing sama from nirama states. Ama has no stated composition, location outside the gut in the earliest sources, or means of detection other than that symptom list.
| Subject area | How disease is held to arise |
|---|---|
| Domain, as recorded | pathology |
| Contested questions | 5 |
| Stated as not known | 11 |
| Classical citations | 13, 9 quoting the text |
| Research papers assessed | 11 |
| Citations checked | 2026-10-08 |
What is contested, and by whom
These are the questions on which the sources genuinely disagree. Each position is given as its source states it. No position is presented as the settled answer, because none of them is.
What is ama? A product of failed digestion, or the doshas themselves?
This is contested.
- Undigested or improperly formed rasa retained in the amashaya because agni is weak. This is Ashtanga Hridaya Su.13/25 and the standard modern teaching.
- Greatly increased doshas that mix with one another and thereby become toxic, on the analogy of poison arising in stored kodrava grain. Vagbhata gives this at Su.13/26 as an alternative immediately after the first definition, so the tradition records the disagreement without resolving it.
- In Charaka the term is used more loosely still, for literally undigested food passed by a vitiated grahani (Ci.15/55-56) and for ama-rasa spreading through the body (Ci.15/74). No single referent is fixed.
Is ama a localized gut phenomenon or a systemic circulating entity?
This is contested.
- Charaka's clearest statements are gut-localized: food not digested in the stomach, food adhering to the pakvashaya, undigested matter discharged in stool.
- Charaka also states that the poison enters urine, stool and the dhatus, and that ama-rasa may spread over the whole body requiring fasting and pachana, which supports a systemic reading.
- Modern Ayurvedic writing treats ama as unambiguously systemic, blocking srotas anywhere in the body. This is the reading that underwrites all the ama-in-rheumatoid-arthritis research, and it is a stronger claim than the earliest source clearly supports.
Does the Ama score measure ama, or does it measure disease activity?
This is contested.
- Pandey and colleagues (PMID 36822147) argue the instrument is an independent disease-status marker precisely because it correlates only weakly with ESR and DAS-28.
- Wagh and colleagues (PMID 42497784) found it correlates strongly with CDAI (r=0.645) and propose merging the Ama-score and CDAI into a single composite measure.
- Wagh and Raut (PMID 38056374) note it has never been tested in any non-rheumatic ama-dominant disease, so its specificity to ama rather than to inflammatory illness is unknown.
Is coated tongue a valid sign of ama?
This is contested.
- It is the sign most relied on in clinical practice and is treated as the canonical external marker of ama.
- The only quantitative test of this located here (PMID 42142499) found no significant correlation between whole-tongue coating index and Ama score in its pre-specified analysis; only a posterior-middle sextant subgroup correlated.
- Tongue coating is independently determined by oral microbial biofilm, hygiene, smoking, hyposalivation and medication, none of which was controlled in that study, so even the positive subgroup finding has an obvious alternative explanation.
Is ama-visha a distinct toxic entity or a descriptive label?
This is contested.
- Charaka Vi.2 states plainly that physicians call it the poison of undigested food because its symptoms resemble poisoning, which is an explicitly analogical naming.
- Much modern writing treats ama-visha as a claim about actual toxicity, and builds endotoxin and free-radical analogies on it. The classical text does not make that claim.
What is not known
Stated rather than left out. Where a negative has actually been searched for rather than assumed, the entry says so.
- What ama is, in any material sense. No composition, no chemical class, no proposed molecule has been isolated or measured. Candidates named in reviews (free radicals, endotoxin/LPS, advanced glycation end products, undigested macromolecules, dysbiotic metabolites) have not been tested against any ama assessment in the literature located here.
- Whether anything measurable actually accumulates in a person judged sama and clears in one judged nirama. No before/after biochemical study of ama-pachana treatment has been located.
- What srotorodha, channel obstruction, corresponds to. This is the load-bearing step converting a digestive failure into systemic disease, and nothing located specifies it. That absence is now a searched one rather than an assumed one, which is what the revision was asked to establish: a PubMed search on 2026-10-06 for 'srotorodha' returned no records at all, and a search for 'srotas' returned 21, whose titles are conceptual appraisals of particular srotas (for example PMID 23723638, a critical appraisal of doshavaha srotas, and PMID 22131705 on herbs acting on mutravaha srotas) and disease-specific case reports; none reports a measurement of channel obstruction. The search did not cover transliteration variants, Sanskrit-language sources, the AYUSH Research Portal or DHARA, or the many Ayurvedic journals that PubMed does not index, so this remains the result of a bounded search and not an established absence. No one has been identified as having attempted to specify the step.
- Whether ama assessment is reproducible between examiners. No interrater reliability figure for an ama score was located in the PubMed searches recorded under gatheringNotes; the only agreement statistic found (0.73-0.76) was for tongue-photograph coating scores, not for ama itself. This gap is load-bearing: the record's description of ama as a scorable symptom cluster assumes only that one examiner can apply the checklist, and says nothing about two.
- The prevalence and distribution of ama scores in healthy populations. One study included 20 healthy volunteers (PMID 42497784) and found their scores indistinguishable from treated RA patients in remission, which is a single small data point and the only normative information located.
- Whether ama scores respond to non-Ayurvedic treatment. If a DMARD-induced remission lowers the ama score as much as ama-directed therapy does, the score is tracking inflammation rather than ama; the remission group in PMID 42497784 was on treatment but the question was not framed or tested. The one blinded trial located in the paradigm ama disease, individualized classical Ayurveda against methotrexate and their combination (PMID 21617554), found no statistically significant difference between arms on DAS28-CRP and ACR response, but it recorded no ama score at all, so it does not answer this question either. It does show that the trial design the question needs is achievable.
- Whether the sama/nirama sequencing rule, that ama must be digested before nourishing or oleating therapy, actually improves outcomes. This is one of the most consequential practical rules in Ayurveda and no comparative trial of the sequencing itself has been located.
- Whether the classical acute ama disorders map onto anything modern. The two public-domain translators are the source of the modern equations, and they do not agree. Kaviratna's Charaka renders Visuchika as cholera and Alasaka as Tympanites in his running text (Lesson XIX, printed p. 217) and repeats both in his own footnotes at Vimanasthana 2 (printed p. 466, each marked '- T.'). Bhishagratna's Sushruta also renders Visuchika as 'cholera' (Sutrasthana XXI, 'Sthana-Samshrayam', printed p. 207), but the occurrences of Alasaka located in his translation render it 'flatulence' (Sutrasthana XLII, printed p. 387) or leave it untranslated, so the alasaka-tympanitis equation should be attributed to Kaviratna alone. No examination of either equation was located in the searches recorded here, and both are probably artefacts of early-twentieth-century translation practice.
- Whether ama is one thing. The concept is applied to acute food poisoning, chronic dyspepsia, coated tongue, rheumatoid inflammation and general malaise; nothing establishes that these share a mechanism rather than a vocabulary.
- Whether ama is a category distinct from agnimandya at all, that is, whether the concept does any work beyond naming the consequences of weak agni. The question can be put from the record's own quoted material: Charaka's list of the signs of indigestion at Ci.15/44-45 already contains 'disgust for food' and 'lassitude of the limbs', which are aruchi and alasya among the ten sama-dosha signs by which ama is identified at Ashtanga Hridaya Su.13/23-24, and a third of those ten, apakti, is impaired digestion itself, so a checklist built from those signs cannot separate ama from weak agni. No source located in this gathering, classical or modern, poses the question, so it is recorded here as unaddressed rather than as a dispute between positions. Nothing in this record answers it.
- What a test of the endotoxin, intestinal-permeability or dysbiosis correlates would consist of. The primary literature these analogies borrow from (PMID 17456850, in mice; PMID 21248165, a review) does not mention ama, and the Ayurvedic writing that invokes them (for example PMID 33281390) measures neither ama nor any marker. The minimum the claim would require is a marker measured in the same patients who are scored sama and nirama, and no study doing that was located.
The terms this concept is built from
Each is a technical term in its own right. Where this site holds a lexicon entry for one, it is linked.
| Term | What it names |
|---|---|
| Agnimandya | Weakening of the digestive fire, the stated precondition. Charaka lists the causes: fasting, indigestible food, overeating, incompatible combinations, unassimilable, heavy, cold, excessively dry or spoiled food, errors in purgation, emesis and oleation, debility from disease, mismatch of place, time and season, and suppression of natural urges. |
| Apakva ahara rasa | The improperly formed first product of digestion. Vagbhata's definition makes ama specifically the rasa dhatu left unformed and retained in the amashaya. |
| Shuktatva / fermentation | The souring or fermenting of retained undigested material. Charaka: food that is not digested 'causes acidity and even becomes poison'. |
| Ama-visha | The acute toxic form, named because its presentation mimics poisoning. In Charaka this arises from incompatible food, eating on top of an undigested meal, or overloading, and is stated to be incurable because the indicated treatments are mutually contradictory. |
| Sama dosha | A dosha to which ama has adhered, held to behave differently from the same dosha in its pure (nirama) state and to require ama-directed treatment first. The sama/nirama distinction governs the sequencing of therapy. |
| Srotorodha | Obstruction of the bodily channels by ama, offered as the mechanism by which a gut-level failure produces systemic disease. It is the least specified step in the whole chain. |
| Sama lakshana | The clinical checklist for ama: channel obstruction, loss of strength, heaviness, torpor of vata, lethargy, impaired digestion, excessive salivation, retention of wastes, anorexia and exhaustion (Ashtanga Hridaya Su.13/23-24). Coated tongue is the sign most used in practice. |
| Langhana and pachana | The therapeutic response: fasting or lightening, then drugs that digest ama without stimulating appetite, before any nourishing or oleating treatment is given. |
| Amavata | The paradigm ama disease, in which ama and vata together lodge in the joints. Described in Madhava Nidana ch. 25 and used in nearly all modern ama research as the clinical model, usually equated with rheumatoid arthritis. |
The classical passages
Each citation gives its address so a reader can check it in a printed edition, our account of what it establishes, and the result of reading it against its source.
Charaka SamhitaChikitsasthana 15 (Grahani-dosha Chikitsita):Kaviratna's Lesson XV, verses 41-43 (cited in the modern vulgate as roughly 15/42-44) · checked against the source
From abstention from all food, from eating food that is indigestible, from eating to excess, from eating food consisting of inharmonious ingredients, from eating food that is not assimilable, or is heavy, or cold, or excessively dry (unoily), or vitiated, from errors in the administration of purgatives, emetics, and oils, from affliction (i.e., weakness, emaciation, &c.,) by diseases, from absence of harmony in respect of place (habitat), time (age), and season, from suppression of the urgings (of nature), the (digestive) fire is vitiated. The vitiated fire cannot digest food that is even light. The food, again, that is not digested, causes acidity and even becomes poison.
The complete classical etiology of ama in one passage: the list of agni-impairing causes, the failure of digestion, souring, and the transition to a poison-like state. This is the primary formation verse.
Charaka SamhitaChikitsasthana 15:Kaviratna's Lesson XV, aphorisms 44-45 (this symptom list is printed immediately above the number 44-45, which also covers the 'terrible poison' sentence quoted in the following entry) · checked against the source
The following are the symptoms of indigestion (of the food taken): flatulence of the stomach, langour of the body, headache, swoons, vertigo, pains in the back and the waist, yawns, lassitude of the limbs, thirst, fever, vomiting, dysentery (white flux), disgust for food, and absence of transformation into healthy stools.
Charaka's own list of the signs of indigestion, that is, of agnimandya with food still undigested. It is quoted here because it overlaps the later sama-dosha checklist by which ama is identified: 'disgust for food' is aruchi, 'lassitude of the limbs' is alasya, and the checklist's apakti is impaired digestion itself. That overlap is the textual reason the question of whether ama is a category distinct from agnimandya can be asked at all; the record does not answer it and records it under notKnown.
Charaka SamhitaChikitsasthana 15:Kaviratna's Lesson XV, verses 44-48 · checked against the source
The food in the stomach that is not digested is a terrible poison. Combining with excited bile, this undigested food, which becomes poison, produces burning of the skin, thirst, diseases of the mouth, sour bile, and other ailments born of (excited bile). Combining with (excited) phlegm, it produces phthisis, inflammation of the Schneiderian membrane, gonorrhoea, and other diseases born of (excited phlegm). Combining with the (excited) wind, it produces diverse diseases that are born of the (excited) wind. When it goes into the urine, that poison causes diseases of the urine. When it goes into the stools, it causes diseases of the abdomen. When combined with 'Rasa' and the rest, it produces diverse diseases born of 'Rasa' and the rest.
The dosha-combination doctrine (what later becomes sama vata, sama pitta, sama kapha) and the claim that ama distributes into excreta and into the dhatus, which is the classical warrant for treating ama as a systemic and not merely a gastric problem.
Charaka SamhitaChikitsasthana 15:Kaviratna's Lesson XV, verses 55-56 · checked against the source
The duct called 'Grahani' is the seat of the digestive fire, and because it takes the food that is eaten, therefore is it called 'Grahani' (taker). It is placed above the (region of the) navel. According to the strength (or weakness) of the (digestive) fire, it becomes extended or contracted. It holds the food in its undigested state. After digestion, it lets out the digested food through its lower opening. When the digestive fire is weak, the 'Grahani' becomes vitiated. It then discharges only undigested food (called Ama).
The anatomical seat and the one place where Kaviratna's translation glosses the term 'Ama' explicitly. Note that here ama is literally undigested food passed in the stool, not an abstract toxin.
Charaka SamhitaChikitsasthana 15:Kaviratna's Lesson XV, aphorism 74 (corrected in the 2026-10-06 revision from '74-75'; the quoted material ends with his aphorism 74, and his 75, on correcting the amashaya, is not quoted) · checked against the source
If undigested food adheres to the 'Pakkasaya', it should be expelled by such drugs as are called 'Dipana'. When the 'ama Rasa' (i.e., the undigested juice of the food taken) spreads over the whole body, fasting and the administration of 'Pachana' (i.e., drugs which assist in digesting undigested food, without increasing the appetite) are prescribable.
The treatment logic and, importantly, the term ama-rasa spreading through the body: the point at which Charaka's gut-level ama becomes a circulating entity. Also fixes the classical distinction between deepana and pachana drugs.
Charaka SamhitaVimanasthana 2 (Trividha-kukshiya Vimana):Kaviratna's aphorisms 17-18 (corrected in the 2026-10-06 revision from '17-19'; the quoted material ends with his 18, and his 19 continues the alasaka description and is not quoted). Cited in the modern vulgate as roughly Vi.2/10-11. · checked against the source
Physicians say that the diseases born of undigested food are of two kinds. These are Visuchika and Alasaka. Of these, that disorder born of undigested food should be known as Visuchika which has an upward and downward tendency of the kind already referred to. We shall now explain what is meant by Alasaka. Of one that is weak, of a weak digestive fire, and of excess of phlegm, that suppresses the urgings of wind, urine, and stools, and that takes food that is solid, heavy, beyond measure, unmoist, cold and dry, such food and drink, oppressed by wind, and having its outlets of escape closed up by phlegm, become exceedingly compressed, and in consequence of their movelessness, lose the power of escaping out (of the system).
The two named acute ama disorders and their mechanisms. The cholera and tympanitis equations attached to this passage are the translator's voice, not Charaka's, and belong to Kaviratna alone: he footnotes his aphorism 17 with "'Visuchika' is identified with the modern cholera. Its chief symptoms, as here declared, are vomiting and purging. - T." and his aphorism 18 with "The disease called Alasaka has been identified with Tympanitis. - T." (both printed p. 466), and he puts the same equations in his running text at Lesson XIX, printed p. 217: "Diseases of the Ama or stomach are of two kinds. They are 1. Alasaka or Tympanites, and 2. Visuchi or Visuchika, i. e., Cholera." These are early and unreliable equations worth flagging as the translator's own.
Charaka SamhitaVimanasthana 2:Kaviratna's aphorism 20 (cited in the modern vulgate as Vi.2/12) · checked against the source
Again, of one that takes such food as is compounded of hostile ingredients, or that takes food after a previous stuffing of the stomach with food, or that takes food anew before the food taken previously has been digested, the (excited) faults are spoken of by physicians as 'the poison of undigested food,' in consequence of their symptoms being similar to those of poison. When such has been the case, it becomes incurable, in consequence of the rapidity of its action and the hostile character of the treatment (that is deducible from the ordinances).
The ama-visha concept in Charaka's own terms, and crucially its basis: the naming is explicitly by resemblance of symptoms to poisoning, not by any claim about the substance itself. This is the single most important verse for reading ama honestly.
Charaka SamhitaVimanasthana 2:Kaviratna's aphorism 16 (cited in the modern vulgate as Vi.2/9) · checked against the source
Even food that is prescribable and that is taken according to proper measure is not digested in consequence of anxiety, grief, fear, wrath, misery, (the inactivity of continuous) lying down, and wakefulness.
That the classical model already treats psychological state, inactivity and sleep loss as sufficient to cause indigestion independent of the food itself. Often cited as the earliest gut-brain statement in the corpus, though the text makes no mechanistic claim.
Sushruta SamhitaSutrasthana 21, the section printed as 'Sthana-Samshrayam':Bhishagratna prints no Sanskrit verse numbers in this passage, only his chapter and section headings; the passage is on printed p. 207 of Vol. I (Sutrasthanam), the page carrying the running head '208 THE SUSHRUTA SAMHITA. [Chap. XXI.' immediately after it. No vulgate verse number is asserted. · checked against the source
These humours, confined in the abdomen, give rise to Gulma (abdominal glands) tumours, internal abscesses (Vidradhi), abdominal dropsy, impaired digestion in the bowels, constipation (Anaha), cholera (Visuchika) and dysentery.
Added in the 2026-10-06 revision to make the record's claim about colonial-era disease equations addressable in Sushruta as well as Charaka. Bhishagratna renders Visuchika as 'cholera' in his running text, so the visuchika-cholera equation is shared by both public-domain translators. He does not share the other half: the occurrences of Alasaka located in his translation render it 'flatulence' (Sutrasthana XLII, printed p. 387: 'Largely and exclusively partaken of, it brings on cough, dyspnoea, flatulence (Alasaka), vomiting...') or leave it untranslated in a list, so the alasaka-tympanitis equation is Kaviratna's alone.
Ashtanga HridayaSutrasthana 13 (Doshopakramaniya):13/25
Vagbhata's definition, which is the one modern textbooks use: through weakness of agni the first dhatu (rasa) is not properly formed, remains vitiated and is retained in the amashaya, and this is called ama. This narrows Charaka's looser 'undigested food' into a specific claim about the first tissue.
Ashtanga HridayaSutrasthana 13:13/26
The competing classical account, given by Vagbhata himself in the next verse: that ama is produced when greatly increased doshas mix with one another, on the analogy of poison arising in stored kodrava grain. That Vagbhata records two accounts side by side is the clearest evidence that the tradition did not settle what ama is.
Ashtanga HridayaSutrasthana 13:13/23-24
The ten signs of sama dosha that constitute the operational definition of ama in clinical practice: srotorodha (channel obstruction), balabhramsha (loss of strength), gaurava (heaviness), anilamudhata (torpor of vata), alasya (lethargy), apakti (impaired digestion), nishtheeva (excess salivation), malasanga (retention of wastes), aruchi (anorexia) and klama (exhaustion), with their opposites defining nirama.
Madhava Nidana25 (Amavata Nidana):25/1-5
The standard samprapti of amavata: mandagni produced by unctuous, cold, heavy and sluggish food, formation of ama, and the concurrent movement of ama and vata into the trika and the joints producing stiffness. This is the source of the disease model used by essentially all modern ama research.
What the research actually shows
Every paper located for this concept, with what it measured and what it does and does not establish. The assessment is ours.
Development and validation of an ama instrument for assessing the disease activity on the basis of constitutional features in Amavata (Rheumatoid Arthritis). · J Ayurveda Integr Med · 2023 · PMID 36822147
Development and clinical testing of a ten-item Ama Assessment Instrument in 79 patients with rheumatoid arthritis. Correlation with ESR was 0.287 at baseline falling to 0.160 by the third follow-up, and with DAS-28 was 0.231 at baseline. The authors nonetheless argue the score is an independent disease-status marker.
How much it shows. Empirical and the most-cited ama instrument study located here, but the headline numbers do not support the headline claim. Correlations of 0.16-0.29 are weak, and the authors' interpretation, that weak correlation with established measures shows the instrument captures something they miss, is equally consistent with it capturing noise or general malaise. Items are drawn from the same classical checklist used to diagnose ama, so textual validation is circular by construction.
Aam assessment instrument for disease activity in Aamavata: Scope and challenges. · J Ayurveda Integr Med · 2023 · PMID 38056374
A published commentary on the above instrument, calling for joint counts to be added, warning about the limitations of patient-reported outcome measures, and noting that the instrument has not been validated for any non-rheumatic ama-dominant disease.
How much it shows. Commentary, not data. Valuable as an in-field acknowledgement that the leading ama instrument is not yet reliable, specific or reproducible, and that ama-specific features have not been adequately developed.
Systemic Ama assessment and Clinical Disease Activity in patients with Amavata (Rheumatoid arthritis). · J Ayurveda Integr Med · 2026 · PMID 42497784
Ama-score compared against the Clinical Disease Activity Index in treatment-naive RA (n=13), RA in remission (n=25) and healthy volunteers (n=20). Spearman r between Ama-score and CDAI was 0.645. The paper states explicitly that the Ama-score did not correlate well with DAS or ESR, which is why CDAI was substituted. Ama-scores in the remission group did not differ from healthy volunteers.
How much it shows. Small empirical study, and honest about the failure that motivated it. The 0.645 correlation is the strongest number located in the ama literature, but CDAI is itself built largely from patient and physician global assessments and tender/swollen joint counts, so a symptom checklist correlating with it may be measuring illness severity rather than ama. Group A n=13 is very small. The comparison against healthy volunteers is the only genuine discriminant-validity element located anywhere in this literature.
Tongue coating, severity of Ama, and disease activity in patients with Rheumatoid Arthritis: A pilot study. · J Ayurveda Integr Med · 2026 · PMID 42142499
Pilot study of tongue coating as a proxy for ama in 22 RA patients, scored from smartphone photographs by five clinicians using the Winkel Tongue Coating Index. The pre-specified correlations failed: WTCI against CDAI r = -0.084 (p=0.71) and WTCI against Ama-score r = -0.161 (p=0.47). Only a post-hoc regional analysis of the posterior-middle sextant reached significance (r=0.479 against Ama-score, r=0.439 against CDAI). Inter-rater agreement was 0.73-0.76.
How much it shows. Empirical and unusually transparent about a negative primary result, which deserves credit. But n=22, the positive findings are post-hoc subgroup analyses of tongue regions, and the abstract's claim of a 'positive association' rests on those rather than on the pre-specified test. Tongue coating is also a known microbial biofilm phenomenon with its own determinants (oral hygiene, smoking, saliva flow, medication), none of which were controlled. This is the closest thing to an objective ama measurement located here, and it did not work as specified.
A clinical study on the role of ama in relation to Grahani Roga and its management by Kalingadi Ghanavati and Tryushnadi Ghrita. · Ayu · 2010 · PMID 22048538
Three-arm clinical study in 66 patients with grahani roga, assessing the role of ama and treating with Kalingadi Ghanavati, Tryushnadi Ghrita or both, with the combination reported as superior.
How much it shows. Open-label, no placebo arm, outcomes scored on rogabala/dehabala/agnibala/chetasabala, all investigator-rated ordinal scales derived from classical categories. No objective endpoint, no biomarker of ama, no blinding. Illustrates the standard design of this literature.
Possible Correlates of Free Radicals and Free Radical Mediated Disorders in Ayurveda with Special Referance to Bhutagni Vyapara and Ama at molecular Level. · Anc Sci Life · 1999 · PMID 22556911
An explicit proposal that ama, arising from disordered bhutagni function, corresponds to free radicals and free-radical-mediated damage.
How much it shows. Narrative and speculative. No data of any kind. It is the archetype of the genre described in this project's reconnaissance: it restates classical doctrine in modern vocabulary, asserts a correlate, calls for research, and stops. Cited here precisely because it is the most-invoked 'modern correlate' of ama and no test of it was located.
Clinical metabolomics investigation of rheumatoid arthritis patients receiving ayurvedic whole system intervention. · J Ayurveda Integr Med · 2024 · PMID 38972279
Clinical metabolomics of rheumatoid arthritis patients receiving a whole-system Ayurvedic intervention, the closest thing located to an untargeted search for metabolic signatures in an ama-model disease.
How much it shows. Exploratory metabolomics in a small uncontrolled cohort. It does not define ama, does not measure an ama score, and cannot attribute any metabolite shift to ama rather than to the intervention, the disease course or diet change. It is therefore not an attempt to test an ama measure and is not counted as one in evidenceState. Relevant as the only study located in this area using an open biochemical method rather than a symptom checklist, and it produced no ama biomarker.
Double-blind, randomized, controlled, pilot study comparing classic ayurvedic medicine, methotrexate, and their combination in rheumatoid arthritis. · J Clin Rheumatol · 2011 · PMID 21617554
Double-blind, randomized, double-dummy pilot trial comparing individualized classical Ayurvedic treatment, methotrexate, and their combination in 43 seropositive RA patients over 36 weeks (MTX plus Ayurvedic placebo n=14, Ayurveda plus MTX placebo n=12, Ayurveda plus MTX n=17). From the abstract: 'There were no statistically significant differences among the 3 groups on the efficacy measures,' with ACR20 of 86% for MTX, 100% for Ayurveda and 82% for the combination, and DAS28-CRP change of -2.4, -1.7 and -2.4. The authors conclude that 'all 3 treatments were approximately equivalent in efficacy, within the limits of a pilot study.'
How much it shows. Added in the 2026-10-06 revision; its absence was a real gap, since it is the one blinded, placebo-controlled randomized trial located in the paradigm ama disease while three open-label investigator-scored studies were included. Its value here is methodological rather than evidential about ama: it demonstrates that classical individualized Ayurvedic treatment can be blinded and double-dummied, and it found no separation between arms at n=43, which is a pilot and underpowered for equivalence. It recorded no ama score and does not use the concept as an outcome, so it cannot settle notKnown item 6, which asks whether an ama score falls under non-Ayurvedic treatment. An erratum (J Clin Rheumatol 2011 Oct) and a published comment (J Clin Rheumatol 2013;19(4):227) are attached to the record in PubMed and were not retrieved.
Therapeutic influence of some dietary articles on gut microbiota in the pathogenesis of rheumatoid arthritis (Amavata) - A review. · Ayu · 2019 · PMID 33281390
Narrative review arguing that the classical pathya (dietary rules) for amavata act on the gut microbiota of RA patients. From the abstract: 'Amavata is a chronic immune-inflammatory systemic disorder caused by the formation of Ama and its association with Vata at Kaphasthana (joints) and can be simulated with rheumatoid arthritis (RA)... Increased inflammatory status in RA is suggestive of gut dysbiosis involving gut microbiota (GM),' concluding that 'Pathya Ahara mentioned for Amavata have a direct link with GM of RA patients.'
How much it shows. Added in the 2026-10-06 revision so that the record's claim about dysbiosis-as-ama is attached to an actual source rather than invoked in the abstract. It is a review of texts and of other people's pharmacology papers: it measures no patient, scores no ama, and assays no microbiota. The 'direct link' in its conclusion is an argument by assembly, from classical diet lists to published anti-inflammatory effects of individual foods, with the ama step never measured. It is evidence of what the field asserts, not evidence for the assertion.
Metabolic endotoxemia initiates obesity and insulin resistance. · Diabetes · 2007 · PMID 17456850
The primary source of the metabolic-endotoxemia hypothesis, in mice. From the abstract: 'we have identified bacterial lipopolysaccharide (LPS) as a triggering factor... a 4-week high-fat diet chronically increased plasma LPS concentration two to three times, a threshold that we have defined as metabolic endotoxemia,' and continuous LPS infusion for 4 weeks reproduced weight gain, raised fasted glycemia and insulinemia, adipose inflammation and hepatic insulin resistance, while CD14 mutant mice 'resisted most of the LPS and high-fat diet-induced features of metabolic diseases.'
How much it shows. Added in the 2026-10-06 revision. Cited for one purpose only: the record previously named endotoxin as a proposed correlate of ama without citing the literature that would have to be engaged, which made the claim unfalsifiable. This is a mouse study in diabetes and obesity. It does not mention ama, Ayurveda, or any symptom checklist, and nothing in it supports or refutes the ama analogy. Its presence here makes the analogy addressable, not supported.
Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. · Physiol Rev · 2011 · PMID 21248165
The standard review of the intestinal-permeability mechanism that the 'leaky gut' version of the ama analogy draws on. From the abstract: 'Zonulin is the only physiological modulator of intercellular tight junctions described so far that is involved in trafficking of macromolecules and, therefore, in tolerance/immune response balance. When the finely tuned zonulin pathway is deregulated in genetically susceptible individuals, both intestinal and extraintestinal autoimmune, inflammatory, and neoplastic disorders can occur.'
How much it shows. Added in the 2026-10-06 revision for the same reason as PMID 17456850: the record invoked intestinal permeability without citing it. A single-author physiology review, not primary data, and the zonulin pathway's identity and assay specificity have themselves been disputed in the barrier-function literature, which this record has not surveyed. It makes no reference to ama. Cited to make the analogy checkable.
How to cite this entry
Age Ayurveda Nighantu, Ama and its formation
, https://nighantu.ageayurveda.com/concept/ama-formation/,
CC BY 4.0. The whole set is downloadable from the concept index.
Machine-readable source: Markdown.
Data exported 2026-10-08.
Educational reference only. This page describes what a body of theory claims and how well it is evidenced. Nothing here is advice, and nothing here describes how any condition should be treated.